Our foreign clinical trial coverage offers a global solution for U.S.-based companies conducting clinical trials overseas.
Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Ecuador, Egypt, Finland, France, Germany, Hong Kong, Hungary, Iceland, Indonesia, Ireland, Italy, Japan, Korea (Republic of), Luxembourg, Malaysia, Mali, Malta, Mexico, Moldova, Netherlands, New Zealand, Norway (medical devices only), Panama, Peru, Philippines, Poland, Portugal, Puerto Rico, Russia, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, Vietnam
Albania, Algeria, Angola, Armenia, Azerbaijan, Bosnia and Herzegovina, Bulgaria, Cambodia, Cameroon, China, Croatia, Dominican Republic, Estonia, Gabon, Georgia, Ghana, Greece, Guatemala, India, Israel, Jordan, Kazakhstan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Macedonia, Malawi, Monaco, Morocco, Nigeria, Oman, Paraguay, Qatar, Romania, Saudi Arabia, Senegal, Serbia, Slovakia, Slovenia, Tanzania, Tunisia, United Arab Emirates, Uganda, Uruguay, Uzbekistan, Venezuela
Risk Transfer: $35 million combined limits; Complex Global Risks: N/A
Biotechnology, Pharmaceutical and Medical Device Companies